| Target Price | $61.20 |
| Price | $41.03 |
| Potential |
49.16%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target PACS Group 2027 .
The average PACS Group target price is $61.20.
This is
49.16%
register free of charge
$65.10
58.66%
register free of charge
$57.57
40.31%
register free of charge
|
|
| A rating was issued by 12 analysts: 11 Analysts recommend PACS Group to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the PACS Group stock has an average upside potential 2027 of
49.16%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 5.29 | 5.95 |
| 29.32% | 12.42% | |
| EBITDA Margin | 6.91% | 11.27% |
| 72.35% | 63.19% | |
| Net Margin | 3.62% | 6.65% |
| 165.62% | 83.62% |
8 Analysts have issued a sales forecast PACS Group 2026 . The average PACS Group sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an PACS Group EBITDA forecast 2026. The average PACS Group EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 PACS Group Analysts have issued a net profit forecast 2026. The average PACS Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.22 | 2.50 |
| 221.05% | 104.92% | |
| P/E | 16.44 | |
| EV/Sales | 1.13 |
8 Analysts have issued a PACS Group forecast for earnings per share. The average PACS Group EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Locked
➜
Locked
|
Locked | Sep 04 2026 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Jul 08 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | May 18 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
JP Morgan:
Locked
➜
Locked
|
Sep 04 2026 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Jul 08 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
May 18 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


